CompanyDrug

Grand Pharmaceutical Receives NMPA Approval for Generic Carbaglu for Hyperammonemia Treatment

CompanyDeals

JW Therapeutics and 2seventy Bio Expand Partnership for Cell Therapy Development

CompanyDeals

Wuhan YZY Biopharma Aims to Raise HKD 220 Million in Hong Kong IPO

CompanyDeals

Exelixis Secures Global Rights to Develop Insilico Medicine’s USP1 Inhibitor ISM3091

CompanyMedical Device

Burning Rock’s CanCatch MRD Product Shows Superiority in Postoperative NSCLC Monitoring

CompanyDrug

Clover Biopharmaceuticals Launches AdimFlu-S, the Only Imported Quadrivalent Influenza Vaccine in China

CompanyDrug

HutchMed Advances Tazverik Phase II Trial for Follicular Lymphoma in China

CompanyDrug

Hybio Pharmaceutical’s Semaglutide Clinical Trial Filing Accepted by China’s NMPA

CompanyDeals

Hasten Biopharmaceutical Secures Licensing Deal for LIB’s Lerodalcibep in Greater China

CompanyDrug

FDA Extends Pfizer’s Comirnaty Vaccine Indication for Omicron XBB.1.5 Variant

CompanyDrug

Amgen’s Lumakras Combo Shows Promising Results in KRAS-mutated NSCLC Early-Stage Trial

CompanyDrug

Gilead’s Trodelvy Combo with MSD’s Keytruda Shows Promise in NSCLC Phase II Trial